Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Everolimus in TSC Patients With SEGA After Response to Standard Therapy
DRKS00005584Phase 4Active, not recruiting
- Sponsor
- Medical University of Lodz
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in tuberous sclerosis complex (TSC) and subependymal giant cell astrocytoma (SEGA), sponsored by Medical University of Lodz. Started Mar 2015; status: active, not recruiting.
02
Drugs
everolimus
03
Conditions
tuberous sclerosis complex (TSC)subependymal giant cell astrocytoma (SEGA)
Beyond the preview
Go deeper on DRKS00005584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005584.